Joshua Shapiro

Examples of Josh’s experience include:

Transactions:

• Representing an LSE-listed medical device company in its $4.2 billion takeover by a leading global medical technology company, which was cleared by the FTC and other international regulators after the negotiation of a global remedy.
• Representing a global private equity firm in its $3.4 billion acquisition of the methacrylates business of one of the largest specialty chemicals companies in the world.
• Representing an NYSE-listed global industrial packaging company in connection with its $1.8 billion acquisition of a recycled paperboard and packaging solutions company.
• Representing a global health care company in connection with its $4.3 billion agreement to acquire a manufacturer of prescription and over-the-counter pharmaceutical products.
• Representing an NYSE-listed global IT services provider in its $14 billion Reverse Morris Trust transaction involving a multinational enterprise information technology company’s global enterprise services segment and a global provider of information technology services and professional services.
• Representing a U.K.-based private equity and venture capital firm in its $385 million acquisition of a U.S.-based concessionaire of airport services.
• Representing an SET-listed global chemical producer in connection with its $314 million acquisition of a manufacturer and supplier of nonwoven hygiene fabrics.
• Representing a global infrastructure fund manager in its $220 million acquisition of an owner and operator of toll bridges and tunnels.
• Representing an ASX-listed manufacturing company in its takeover by a Japan-based construction equipment company.
• Representing a Dutch telecommunications company in the sale of a wholly owned U.S. subsidiary to a global provider of communications solutions.
• Representing a global health service company in its $54 billion merger with a managed health care company.
• Representing a global pharmaceutical company in its $5.4 billion acquisition of an animal health company.
• Representing a commercial airline in its slot transaction with another commercial airline.
• Representing a multinational pharmaceutical corporation in its $68 billion acquisition of another global pharmaceutical company.

Litigation:

• Representing a Thailand-based producer of seafood products and a U.S.-based provider of packaged seafood in a class action litigation involving price fixing in the packaged tuna industry.
• Representing a UK-based banking and financial services company in multidistrict class action litigation alleging violations of Sections 1 and 2 of the Sherman Act.
• Representing a European banking group in multidistrict class action litigation alleging antitrust violations in the municipal derivatives industry.
• Representing the largest U.S. dairy in arbitration involving claims alleging manipulation of the spot cheese market and milk futures contracts.
• Representing a U.S. brewing company in a confidential arbitration involving breach of contract and theft of trade secret claims.

• “Selling Through Dealers – Antitrust Guidelines for Manufacturers,” Thompson Hine Antitrust Law Guidelines, April 2021
• Co-author, “Proposed Amendment to HSR Rules Would Increase Filing Obligations for Private Equity Funds,” Thompson Hine Business Law Update, Spring 2021
• Co-author, "Antitrust Agencies Suspend Early Termination - Temporary or Indefinite?" Thompson Hine Antitrust, Competition & Distribution Update, February 2021
• Co-author, "HSR Filing Thresholds Decrease in 2021," Thompson Hine Antitrust, Competition & Distribution Update, February 2021
• Co-author, "Justice Department Issues First Update to Antitrust Merger Remedies Guidance in a Decade," Thompson Hine Antitrust, Competition & Distribution Update, September 2020
• Co-author, “Beware Antitrust Risks in Syndicated Lending, ”Law360.com, March 2017

• Included on New York Super Lawyers Rising Stars list (2015-2017)

Professional Associations

• American Bar Association, Antitrust Section
• New York City Bar Association, Antitrust and Trade Regulation Committee (2016-2019)